Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec;35(9):2437-2440.
doi: 10.1007/s40620-022-01405-x. Epub 2022 Aug 16.

Screening for Fabry disease in Argentina in male patients with chronic kidney disease at all stages

Choua Martin  1 , Neumann Pablo  2 , Quieto Pedro  1 , Rozenfeld Paula  3   4 ; Argentine renal group on Fabry disease
Collaborators, Affiliations

Screening for Fabry disease in Argentina in male patients with chronic kidney disease at all stages

Choua Martin et al. J Nephrol. 2022 Dec.

Abstract

We report three patients diagnosed with Fabry disease through a screening study which included individuals suffering from chronic kidney disease (CKD) at any stage. The study recruited 1740 male patients, and three Fabry patients were diagnosed, resulting in a frequency of 0.17%. The analysis by CKD stage group revealed frequencies of 3.03%, 0.77% and 0.17%, in CKD1, CKD3 and CKD5, respectively. Pedigree analysis was carried out for these families, with a high ratio index: pedigree (1:16). This study underlines the importance of considering Fabry disease in the differential diagnosis at every stage of CKD, including the early ones, and stresses the possibility of finding patients with late onset phenotypes.

Keywords: Alpha galactosidase A; Chronic kidney disease; Fabry disease; High risk screening.

PubMed Disclaimer

References

    1. Eng CM et al (1994) Fabry disease: twenty-three mutations including sense and antisense CPG alterations and identification of a deletional hot-spot in the α-galactosidase A gene. Hum Mol Genet 3:1795–1799 - DOI - PubMed
    1. Arends M et al (2017) Characterization of classical and nonclassical fabry disease: a multicenter study. J Am Soc Nephrol 28:1631–1641 - DOI - PubMed
    1. Marchesoni CL et al (2010) Misdiagnosis in Fabry disease. J Pediatr 156:828–831 - DOI - PubMed
    1. Donehy D et al (2018) Fabry Disease: prevalence of affected males and heterozygotes with pathogenic GLA mutations identified by screening renal, cardiac and stroke clinics, 1995–2017. J Med Genet 55(4):261–268 - DOI
    1. Capuano I et al (2019) Identifying Fabry patients in dialysis population: prevalence of GLA mutations by renal clinic screening, 1995–2019. J Nephrol 33:569–581 - DOI - PubMed

Publication types

Substances

Grants and funding